These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38591264)

  • 1. Impact of a Chronic Total Coronary Occlusion on the Incidence of Appropriate Implantable Cardioverter-Defibrillator Shocks and Mortality: A Substudy of the Dutch Outcome in ICD Therapy (DO-IT)) Registry.
    van Veelen A; Verstraelen TE; Somsen YBO; Elias J; van Dongen IM; Delnoy PPHM; Scholten MF; Boersma LVA; Maass AH; Strikwerda S; Firouzi M; Allaart CP; Vernooy K; Grauss RW; Tukkie R; Knaapen P; Zwinderman AH; Dijkgraaf MGW; Claessen BEPM; van Barreveld M; Wilde AAM; Henriques JPS;
    J Am Heart Assoc; 2024 Apr; 13(8):e032033. PubMed ID: 38591264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
    Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
    JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long-Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator (the eCTOpy-in-ICD Study).
    van Dongen IM; Yilmaz D; Elias J; Claessen BEPM; Delewi R; Knops RE; Wilde AAM; van Erven L; Schalij MJ; Henriques JPS
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29720502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular arrhythmias among implantable cardioverter-defibrillator recipients for primary prevention: impact of chronic total coronary occlusion (VACTO Primary Study).
    Nombela-Franco L; Mitroi CD; Fernández-Lozano I; García-Touchard A; Toquero J; Castro-Urda V; Fernández-Diaz JA; Perez-Pereira E; Beltrán-Correas P; Segovia J; Werner GS; Javier G; Luis AP
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):147-54. PubMed ID: 22205684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of chronic total coronary occlusion on long-term outcomes in implantable cardioverter-defibrillator recipients with ischaemic heart disease.
    Nishikawa T; Fujino M; Nakajima I; Asaumi Y; Kataoka Y; Anzai T; Kusano K; Noguchi T; Goto Y; Nishimura K; Miyamoto Y; Kiso K; Yasuda S
    Europace; 2017 Jul; 19(7):1153-1162. PubMed ID: 27738062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of ventricular arrhythmias in survivors of out-of-hospital cardiac arrest with chronic total coronary occlusion.
    Yap SC; Sakhi R; Theuns DAMJ; Yasar YE; Bhagwandien RE; Diletti R; Zijlstra F; Szili-Torok T
    Heart Rhythm; 2018 Jan; 15(1):124-129. PubMed ID: 28917556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Successful Chronic Coronary Total Occlusion Recanalization on Recurrence of Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Recipients for Ischemic Cardiomyopathy (VACTO PCI Study).
    Iannaccone M; Nombela-Franco L; Gallone G; Annone U; Di Marco A; Giannini F; Ayoub M; Sardone A; Amat-Santos I; Fernandez-Lozano I; Barbero U; Dusi V; Toselli M; Petretta A; de Salvia A; Boccuzzi G; Colangelo S; Anguera I; D'Ascenzo F; Colombo A; De Ferrari GM; Escaned J; Garbo R; Mashayekhi K
    Cardiovasc Revasc Med; 2022 Oct; 43():104-111. PubMed ID: 35398008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of preventive substrate catheter ablation on implantable cardioverter-defibrillator interventions in patients with ischaemic cardiomyopathy and infarct-related coronary chronic total occlusion.
    Žižek D; Mrak M; Jan M; Zupan Mežnar A; Ivanovski M; Žlahtič T; Kajdič N; Antolič B; Klemen L; Skale R; Avramovič Gregorič J; Štublar J; Pernat A; Šinkovec M
    Europace; 2024 May; 26(5):. PubMed ID: 38657209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic total occlusion in an infarct-related coronary artery and the risk of appropriate ICD therapies.
    Di Marco A; Anguera I; Teruel L; Muntane G; Campbell NG; Fox DJ; Brown B; Skene C; Davidson N; Leon V; Dallaglio P; Elzein H; Garcia-Romero E; Gomez-Hospital JA; Cequier A
    J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1169-1178. PubMed ID: 28675508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revascularization of coronary chronic total occlusions in an infarct-related artery and recurrence of ventricular arrhythmias among patients with secondary prevention implantable cardioverter defibrillator.
    Di Marco A; Anguera I; Nombela-Franco L; Oloriz T; Teruel L; Rodriguez Mañero M; Toquero J; León V; Dallaglio P; Perez Guerrero A; Salazar CH; Escaned J; Asso Abadía A; Gomez Hospital JA; Cequier A
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):E1-E11. PubMed ID: 32460428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Chronic Total Occlusions and Coronary Revascularization on All-Cause Mortality and the Incidence of Ventricular Arrhythmias in Patients With Ischemic Cardiomyopathy.
    Raja V; Wiegn P; Obel O; Christakopoulos G; Christopoulos G; Rangan BV; Roesle M; Abdullah SM; Luna M; Addo T; Ayers C; Garcia S; de Lemos JA; Banerjee S; Brilakis ES
    Am J Cardiol; 2015 Nov; 116(9):1358-62. PubMed ID: 26341182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of coronary chronic total occlusion on recurrences of ventricular tachyarrhythmias and ICD therapies.
    Behnes M; Mashayekhi K; Kuche P; Kim SH; Schupp T; von Zworowsky M; Reiser L; Bollow A; Taton G; Reichelt T; Borggrefe M; Ellguth D; Engelke N; Weidner K; Lindner S; Müller J; Ansari U; Meininghaus DG; Bertsch T; Lang S; Akin I
    Clin Res Cardiol; 2021 Feb; 110(2):281-291. PubMed ID: 33150467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis of Risk of Ventricular Arrhythmias and All-Cause Mortality in Patients With Chronic Total Occlusion of a Coronary Artery and/or Implantable Cardioverter-Defibrillator.
    Wang ZQ; Qiang H; Luo X; Li W; Guo K; Li YG
    Am J Cardiol; 2018 May; 121(10):1149-1154. PubMed ID: 29548677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention implantable cardioverter-defibrillators.
    Sroubek J; Matos J; Locke A; Kaplinskiy V; Levine YC; Shen C; Buxton AE
    Heart Rhythm; 2021 Jan; 18(1):71-78. PubMed ID: 32866691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.
    Gupta A; Harrington M; Albert CM; Bajaj NS; Hainer J; Morgan V; Bibbo CF; Bravo PE; Osborne MT; Dorbala S; Blankstein R; Taqueti VR; Bhatt DL; Stevenson WG; Di Carli MF
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1200-1210. PubMed ID: 30236394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
    Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
    Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of chronic total occlusion on ventricular arrhythmia and mortality in ischaemic cardiomyopathy patient with implantable cardiac defibrillator: a meta-analysis.
    Vutthikraivit W; Rattanawong P; Kewcharoen J; Kanitsoraphan C; Pachariyanon P; Suchartlikitwong S; Klomjit S; Tantrachoti P
    Acta Cardiol; 2019 Oct; 74(5):395-402. PubMed ID: 30328769
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of signal-averaged electrocardiography findings on appropriate shocks in prophylactic implantable cardioverter defibrillator patients with nonischemic systolic heart failure.
    Nomoto M; Suzuki A; Shiga T; Shoda M; Hagiwara N
    BMC Cardiovasc Disord; 2022 Aug; 22(1):374. PubMed ID: 35974317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of successful chronic total occlusion percutaneous coronary intervention on long-term clinical outcomes in real world.
    Gong X; Zhou L; Ding X; Chen H; Li H
    BMC Cardiovasc Disord; 2021 Apr; 21(1):182. PubMed ID: 33858349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.